Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.
Nicholas HernandezIsabelle MelkiHuie JingTanwir HabibSusie Shih Yin HuangJeffrey DanielsonTomasz KulaScott DrutmanSerkan BelkayaVimel RattinaLazaro Lorenzo-DiazAnais BoulaiYoann RoseNaoki KitabayashiMathieu P RoderoCecile DumaineStéphane BlancheMarie-Noëlle LebrasMan Chun LeungLisa Sara MathewBertrand BoissonShen-Ying ZhangStephanie Boisson-DupuisSilvia Clara GilianiDamien ChaussabelLuigi Daniele NotarangeloStephen J ElledgeMichael J CiancanelliLaurent AbelQian ZhangNico MarrYanick J CrowHelen C SuJean Laurent CasanovaPublished in: The Journal of experimental medicine (2018)
Life-threatening pulmonary influenza can be caused by inborn errors of type I and III IFN immunity. We report a 5-yr-old child with severe pulmonary influenza at 2 yr. She is homozygous for a loss-of-function IRF9 allele. Her cells activate gamma-activated factor (GAF) STAT1 homodimers but not IFN-stimulated gene factor 3 (ISGF3) trimers (STAT1/STAT2/IRF9) in response to IFN-α2b. The transcriptome induced by IFN-α2b in the patient's cells is much narrower than that of control cells; however, induction of a subset of IFN-stimulated gene transcripts remains detectable. In vitro, the patient's cells do not control three respiratory viruses, influenza A virus (IAV), parainfluenza virus (PIV), and respiratory syncytial virus (RSV). These phenotypes are rescued by wild-type IRF9, whereas silencing IRF9 expression in control cells increases viral replication. However, the child has controlled various common viruses in vivo, including respiratory viruses other than IAV. Our findings show that human IRF9- and ISGF3-dependent type I and III IFN responsive pathways are essential for controlling IAV.
Keyphrases
- dendritic cells
- induced apoptosis
- cell cycle arrest
- immune response
- respiratory syncytial virus
- mental health
- emergency department
- rheumatoid arthritis
- poor prognosis
- signaling pathway
- endothelial cells
- dna methylation
- copy number
- wild type
- cancer therapy
- long non coding rna
- interstitial lung disease
- systemic sclerosis
- drug induced